Abstract
With the advent of microRNA (miRNA) we are compelled to revise our understanding of the mechanisms underlying gene regulation during health and disease. A miRNA is approximately 21 ribonucleotides long, genetically encoded, with a potential to recognize multiple mRNA targets guided by sequence complementarity and RNA-binding proteins. This class of molecules is functionally versatile, with the capacity to specifically inhibit translation initiation or elongation, as well as induce mRNA degradation, through predominantly targeting the 3′-untranslated regions of mRNA. Early on it was realized that the levels of individual miRNA varied under different developmental, biological, or pathological conditions, thus implicating these molecules in normal and pathological cellular attributes. In this chapter, we will discuss how the functions of miRNA relate to our existing knowledge on post-transcriptional regulation of gene expression that is the underlying mechanism of many diseases, including cardiac hypertrophy and failure, and their potential as biomarkers and therapeutic targets in diseases.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
- Chronic Lymphocytic Leukemia
- Hepatocyte Growth Factor
- Proliferate Cell Nuclear Antigen
- Cardiac Hypertrophy
- Serum Response Factor
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Abdellatif M, Packer SE, Michael LH et al (1998) A Ras-dependent pathway regulates RNA polymerase II phosphorylation in cardiac myocytes: implications for cardiac hypertrophy. Mol Cell Biol 18:6729–6736
Bassell GJ, Powers CM, Taneja KL et al (1994) Single mRNAs visualized by ultrastructural in situ hybridization are principally localized at actin filament intersections in fibroblasts. J Cell Biol 126:863–876
Bentwich I (2005) Prediction and validation of microRNAs and their targets. FEBS Lett 579:5904–5910
Beyer A, Hollunder J, Nasheuer HP et al (2004) Post-transcriptional expression regulation in the yeast Saccharomyces cerevisiae on a genomic scale. Mol Cell Proteomics 3:1083–1092
Bloomston M, Frankel WL, Petrocca F et al (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297:1901–1908
Blow MJ, Grocock RJ, van Dongen S et al (2006) RNA editing of human microRNAs. Genome Biol 7:4
Boehm M, Slack FJ (2006) MicroRNA control of lifespan and metabolism. Cell Cycle 5:837–840
Borchert GM, Lanier W, Davidson BL (2006) RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 13:1097–1101
Brennecke J, Stark A, Russell RB et al (2005) Principles of microRNA-target recognition. PLoS Biol 3:0404–0418
Calin GA, Dumitru CD, Shimizu M et al (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99:15524–15529
Calin GA, Liu CG, Sevignani C et al (2004a) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 101:11755–11760
Calin GA, Sevignani C, Dumitru CD et al (2004b) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101:2999–3004
Care A, Catalucci D, Felicetti F et al (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13:613–618
Chang S, McKinsey TA, Zhang CL et al (2004) Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol Cell Biol 24:8467–8476
Chen CY, Croissant J, Majesky M et al (1996) Activation of the cardiac alpha-actin promoter depends upon serum response factor, Tinman homologue, Nkx-2.5, and intact serum response elements. Dev Genet 19:119–130
Chen IY, Lypowy J, Pain J et al (2006) Histone H2A.z is essential for cardiac myocyte hypertrophy but opposed by silent information regulator 2alpha. J Biol Chem 281:19369–19377
Cheng Y, Ji R, Yue J et al (2007) MicroRNAs are aberrantly expressed in hypertrophic heart. Do they play a role in cardiac hypertrophy? Am J Pathol 170:1831–1840
Cimmino A, Calin GA, Fabbri M et al (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102:13944–13949
Cooperstock RL, Lipshitz HD (1997) Control of mRNA stability and translation during Drosophila development. Semin Cell Dev Biol 8:541–549
Costinean S, Zanesi N, Pekarsky Y et al (2006) Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA 103:7024–7029
Dai YS, Markham BE (2001) p300 Functions as a coactivator of transcription factor GATA-4. J Biol Chem 276:37178–37185
Dews M, Homayouni A, Yu D et al (2006) Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38:1060–1065
Eis PS, Tam W, Sun L et al (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 102:3627–3632
Esquela-Kerscher A, Slack FJ (2006) Oncomirs – microRNAs with a role in cancer. Nat Rev Cancer 6:259–269
Farh KK, Grimson A, Jan C et al (2005) The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310:1817–1821
Formigli L, Ibba-Manneschi L, Perna AM et al (2003) Altered Cx43 expression during myocardial adaptation to acute and chronic volume overloading. Histol Histopathol 18:359–369
Frankel DS, Piette JD, Jessup M et al (2006) Validation of prognostic models among patients with advanced heart failure. J Card Fail 12:430–438
Fulci V, Chiaretti S, Goldoni M et al (2007) Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109:4944–4951
Gottlieb E (1990) Messenger RNA transport and localization. Curr Opin Cell Biol 2:1080–1086
Griffiths-Jones S (2004) The microRNA Registry. Nucleic Acids Res 32:D109–D111
Griffiths-Jones S, Grocock RJ, van Dongen S et al (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34:D140–144
Gusterson RJ, Jazrawi E, Adcock IM et al (2003) The transcriptional co-activators CREB-binding protein (CBP) and p300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity. J Biol Chem 278:6838–6847
Gygi SP, Rochon Y, Franza BR et al (1999) Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19:1720–1730
Humphreys DT, Westman BJ, Martin DI et al (2005) MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci USA 102:16961–16966
Ioannidis JP (2005) Microarrays and molecular research: noise discovery? Lancet 365:454–455
Iorio MV, Ferracin M, Liu CG et al (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065–7070
Ito H, Hiroe M, Hirata Y et al (1993) Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation 87:1715–1721
Iwata K, Sawa Y, Kitagawa-Sakakida S et al (2005) Gene transfection of hepatocyte growth factor attenuates the progression of cardiac remodeling in the hypertrophied heart. J Thorac Cardiovasc Surg 130:719–725
Jegga AG, Chen J, Gowrisankar S et al (2007) GenomeTrafac: a whole genome resource for the detection of transcription factor binding site clusters associated with conventional and microRNA encoding genes conserved between mouse and human gene orthologs. Nucleic Acids Res 35:D116–D121
Ji R, Cheng Y, Yue J et al (2007) MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 100:1579–1588
John B, Enright AJ, Aravin A et al (2004) Human MicroRNA targets. PLoS Biol 2:1862–1879
Johnatty SE, Dyck JR, Michael LH et al (2000) Identification of genes regulated during mechanical load-induced cardiac hypertrophy. J Mol Cell Cardiol 32:805–815
Kawahara Y, Zinshteyn B, Sethupathy P et al (2007) Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 315:1137–1140
Killeen M, Coulombe B, Greenblatt J (1992) Recombinant TBP, transcription factor IIB, and RAP30 are sufficient for promoter recognition by mammalian RNA polymerase II. J Biol Chem 267:9463–9466
Krek A, Grun D, Poy MN et al (2005) Combinatorial microRNA target predictions. Nat Genet 37:495–500
Krutzfeldt J, Rajewsky N, Braich R et al (2005) Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438:685–689
Kulshreshtha R, Ferracin M, Wojcik SE et al (2007) A microRNA signature of hypoxia. Mol Cell Biol 27:1859–1867
Kutay H, Bai S, Datta J et al (2006) Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 99:671–678
Lagos-Quintana M, Rauhut R, Lendeckel W et al (2001) Identification of novel genes coding for small expressed RNAs. Science 294:853–858
Lagos-Quintana M, Rauhut R, Yalcin A et al (2002) Identification of tissue-specific microRNAs from mouse. Curr Biol 12:735–739
Lau NC, Lim LP, Weinstein EG et al (2001) An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294:858–862
Lee RC, Ambros V (2001) An extensive class of small RNAs in Caenorhabditis elegans. Science 294:862–864
Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843–854
Lee Y, Jeon K, Lee JT et al (2002) MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 21:4663–4670
Lee EJ, Gusev Y, Jiang J et al (2006) Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120:1046–1054
Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20
Lim LP, Lau NC, Garrett-Engele P et al (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433:769–773
Linsley PS, Schelter J, Burchard J et al (2007) Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 27:2240–2252
Lu J, Getz G, Miska EA et al (2005) MicroRNA expression profiles classify human cancers. Nature 435:834–838
Luciano DJ, Mirsky H, Vendetti NJ et al (2004) RNA editing of a miRNA precursor. RNA 10:1174–1177
Lypowy J, Chen IY, Abdellatif M (2005) An alliance between RAS GTPASE-activating protein, filamin C, and G3BP regulates myocyte growth. J Biol Chem 280:35717–25728
Maas S, Rich A (2000) Changing genetic information through RNA editing. Bioessays 22:790–802
Macabasco-O’Connell A, Miller PS (2006) Biomarkers for heart failure. Prog Cardiovasc Nurs 21:215–218
Michael MZ, SM OC, van Holst Pellekaan NG et al (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1:882–891
Michiels S, Koscielny S, Hill C (2005) Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 365:488–492
Molkentin JD, Lu JR, Antos CL et al (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215–228
Nakamura T, Matsumoto K, Mizuno S et al (2005) Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. Am J Physiol Heart Circ Physiol 288:H2131–2139
O’Donnell KA, Wentzel EA, Zeller KI et al (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435:839–843
Olsen PH, Ambros V (1999) The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol 216:671–680
Poy MN, Eliasson L, Krutzfeldt J et al (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432:226–230
Reinhart BJ, Slack FJ, Basson M et al (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403:901–906
Reis-Filho JS, Westbury C, Pierga JY (2006) The impact of expression profiling on prognostic and predictive testing in breast cancer. J Clin Pathol 59:225–231
Ricci R, Eriksson U, Oudit GY et al (2005) Distinct functions of junD in cardiac hypertrophy and heart failure. Genes Dev 19:208–213
Rodriguez A, Griffiths-Jones S, Ashurst JL et al (2004) Identification of mammalian microRNA host genes and transcription units. Genome Res 14:1902–1910
Sachs A (2000) Translational control of gene expression. Cold Spring Harbor Laboratory, Cold Spring Harbor
Samuel JL, Barrieux A, Dufour S et al (1991) Accumulation of fetal fibronectin mRNAs during the development of rat cardiac hypertrophy induced by pressure overload. J Clin Invest 88:1737–1746
Sano M, Abdellatif M, Oh H et al (2002) Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy. Nat Med 8:1310–1317
Sayed D, Hong C, Chen IY et al (2007) MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100:416–424
Seggerson K, Tang L, Moss EG (2002) Two genetic circuits repress the Caenorhabditis elegans heterochronic gene lin-28 after translation initiation. Dev Biol 243:215–225
Shcherbata HR, Hatfield S, Ward EJ et al (2006) The MicroRNA pathway plays a regulatory role in stem cell division. Cell Cycle 5:172–175
Sokol NS, Ambros V (2005) Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth. Genes Dev 19:2343–2354
Swalla BJ, Jeffery WR (1996) PCNA mRNA has a 3′UTR antisense to yellow crescent RNA and is localized in ascidian eggs and embryos. Dev Biol 178:23–34
Thomson JM, Newman M, Parker JS et al (2006) Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 20:2202–2207
Tran N, McLean T, Zhang X et al (2007) MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 358:12–17
van Rooij E, Sutherland LB, Liu N et al (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103:18255–18260
van Rooij E, Sutherland LB, Qi X et al (2007) Control of stress-dependent cardiac growth and gene expression by a MicroRNA. Science 316:575–579
Volinia S, Calin GA, Liu CG et al (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257–2261
Wada H, Ivester CT, Carabello BA et al (1996) Translational initiation factor eIF-4E. A link between cardiac load and protein synthesis. J Biol Chem 271:8359–8364
Wang Y, Liu CL, Storey JD et al (2002) Precision and functional specificity in mRNA decay. Proc Natl Acad Sci USA 99:5860–5865
Weber B, Stresemann C, Brueckner B et al (2007) Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 6:1001–1005
Wu L, Fan J, Belasco JG (2006) MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci USA 103:4034–4039
Yanaihara N, Caplen N, Bowman E et al (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9:189–198
Yang B, Lin H, Xiao J et al (2007) The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13:486–491
Zhang X, Azhar G, Chai J et al (2001) Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am J Physiol Heart Circ Physiol 280:H1782–1792
Zhang CL, McKinsey TA, Chang S et al (2002) Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110:479–488
Zhao Y, Samal E, Srivastava D (2005) Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436:214–220
Zhao Y, Ransom JF, Li A et al (2007) Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1–2. Cell 129:303–317
Zhou X, Ruan J, Wang G et al (2007) Characterization and identification of MicroRNA core promoters in four model species. PLoS Comput Biol 3:0412–0423
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Abdellatif, M. (2008). MicroRNAs and Their Potential. In: Erdmann, V.A., Poller, W., Barciszewski, J. (eds) RNA Technologies in Cardiovascular Medicine and Research. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78709-9_2
Download citation
DOI: https://doi.org/10.1007/978-3-540-78709-9_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-78708-2
Online ISBN: 978-3-540-78709-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)